You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 30, 2024

Meda Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for MEDA PHARMS, and what generic and branded alternatives to MEDA PHARMS drugs are available?

MEDA PHARMS has six approved drugs.

Summary for Meda Pharms

US Patents:	0
Tradenames:	6
Ingredients:	6
NDAs:	6

Drugs and US Patents for Meda Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Meda Pharms	REGLAN ODT	metoclopramide hydrochloride	TABLET, ORALLY DISINTEGRATING;ORAL	021793-002	Jun 10, 2005		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Meda Pharms	BUTISOL SODIUM	butabarbital sodium	ELIXIR;ORAL	085380-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Meda Pharms	SOMA COMPOUND	aspirin; carisoprodol	TABLET;ORAL	012365-005	Jul 11, 1983		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Meda Pharms	THYRO-BLOCK	potassium iodide	TABLET;ORAL	018307-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Meda Pharms	SOMA COMPOUND W/ CODEINE	aspirin; carisoprodol; codeine phosphate	TABLET;ORAL	012366-002	Jul 11, 1983		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Meda Pharms	REGLAN ODT	metoclopramide hydrochloride	TABLET, ORALLY DISINTEGRATING;ORAL	021793-001	Jun 10, 2005		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Meda Pharms

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Meda Pharms	REGLAN ODT	metoclopramide hydrochloride	TABLET, ORALLY DISINTEGRATING;ORAL	021793-001	Jun 10, 2005	6,024,981	⤷ Subscribe
Meda Pharms	SOMA COMPOUND	aspirin; carisoprodol	TABLET;ORAL	012365-005	Jul 11, 1983	4,534,973	⤷ Subscribe
Meda Pharms	REGLAN ODT	metoclopramide hydrochloride	TABLET, ORALLY DISINTEGRATING;ORAL	021793-002	Jun 10, 2005	6,221,392	⤷ Subscribe
Meda Pharms	REGLAN ODT	metoclopramide hydrochloride	TABLET, ORALLY DISINTEGRATING;ORAL	021793-001	Jun 10, 2005	6,221,392	⤷ Subscribe
Meda Pharms	REGLAN ODT	metoclopramide hydrochloride	TABLET, ORALLY DISINTEGRATING;ORAL	021793-002	Jun 10, 2005	6,024,981	⤷ Subscribe
Meda Pharms	SOMA COMPOUND W/ CODEINE	aspirin; carisoprodol; codeine phosphate	TABLET;ORAL	012366-002	Jul 11, 1983	4,534,974	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Meda Pharms

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.